- Home
- OBIO vs VOXR Comparison
OBIO vs VOXR Comparison
Compare OBIO & VOXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- VOXR
- Stock Information
- Founded
- OBIO 2017
- VOXR 2014
- Country
- OBIO United States
- VOXR United States
- Employees
- OBIO N/A
- VOXR N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- VOXR Precious Metals
- Sector
- OBIO Health Care
- VOXR Basic Materials
- Exchange
- OBIO Nasdaq
- VOXR Nasdaq
- Market Cap
- OBIO 151.3M
- VOXR N/A
- IPO Year
- OBIO N/A
- VOXR N/A
- Fundamental
- Price
- OBIO $4.28
- VOXR $2.90
- Analyst Decision
- OBIO Strong Buy
- VOXR
- Analyst Count
- OBIO 5
- VOXR 0
- Target Price
- OBIO $15.40
- VOXR N/A
- AVG Volume (30 Days)
- OBIO 51.3K
- VOXR 202.0K
- Earning Date
- OBIO 05-12-2025
- VOXR 05-07-2025
- Dividend Yield
- OBIO N/A
- VOXR 1.72%
- EPS Growth
- OBIO N/A
- VOXR N/A
- EPS
- OBIO N/A
- VOXR N/A
- Revenue
- OBIO $2,647,000.00
- VOXR $11,047,763.00
- Revenue This Year
- OBIO $22.61
- VOXR $16.51
- Revenue Next Year
- OBIO $16.64
- VOXR $4.60
- P/E Ratio
- OBIO N/A
- VOXR N/A
- Revenue Growth
- OBIO N/A
- VOXR N/A
- 52 Week Low
- OBIO $3.75
- VOXR $1.93
- 52 Week High
- OBIO $8.87
- VOXR $3.24
- Technical
- Relative Strength Index (RSI)
- OBIO 45.19
- VOXR 66.11
- Support Level
- OBIO $4.14
- VOXR $2.86
- Resistance Level
- OBIO $4.67
- VOXR $3.00
- Average True Range (ATR)
- OBIO 0.34
- VOXR 0.12
- MACD
- OBIO 0.06
- VOXR 0.03
- Stochastic Oscillator
- OBIO 51.70
- VOXR 87.14
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.